Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 EUR | -1.43% | -2.13% | -86.13% |
Sales 2024 * | 39.35M 36.77M | Sales 2025 * | 58.17M 54.35M | Capitalization | 80.48M 75.2M |
---|---|---|---|---|---|
Net income 2024 * | -119M -111M | Net income 2025 * | -78M -72.88M | EV / Sales 2024 * | -1.19 x |
Net cash position 2024 * | 127M 119M | Net cash position 2025 * | 54.53M 50.95M | EV / Sales 2025 * | 0.45 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-1.41
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 week | -2.13% | ||
Current month | +2.22% | ||
1 month | +9.52% | ||
3 months | -83.07% | ||
6 months | -82.42% | ||
Current year | -86.13% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Date | Price | Change |
---|---|---|
24-06-14 | 1.38 | -1.43% |
24-06-13 | 1.4 | +0.72% |
24-06-12 | 1.39 | 0.00% |
24-06-11 | 1.39 | -6.08% |
24-06-10 | 1.48 | +4.96% |
Real-time BOERSE MUENCHEN, June 14, 2024 at 03:43 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock